Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 536586

Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipaemia


Turk, Zdenka; Ljubić, Spomenka; Boras, Jozo
Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipaemia // Physiological research, 63 (2014), 2; 199-205 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 536586 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipaemia

Autori
Turk, Zdenka ; Ljubić, Spomenka ; Boras, Jozo

Izvornik
Physiological research (0862-8408) 63 (2014), 2; 199-205

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
advanced glycation pathway type 2 diabetes macrovascular disease AGE/esRAGE ratio

Sažetak
Endogenous secretory receptor (esRAGE) for advanced glycation end-product (AGE) acts as decoy for AGEs. The AGE-to-esRAGE ratio was hypothesized to be implicated in diabetic vasculopathy. We investigated an association of esRAGE and methylglyoxal-adducts serum level, as well as AGE- to-esRAGE ratio in subpopulation of diabetic patients with or without concomitant hyperlipemia and macrovascular disease in history. In diabetes with concomitant hyperlipemia esRAGE was significantly decreased compared to hyperlipemia with normal glucose metabolism (0.306±0.2 vs. 0.367±0.1 ; p=0.019) or diabetes alone (0.306±0.2 vs. 0.404±0.1 ; p=0.004). High AGE/esRAGE ratio, found in diabetic patients with hyperlipemia, pointed to increased production of AGEs and low expression of esRAGE. In multivariable analysis adjusted for several confounding factors, increased AGE/esRAGE ratio was recognized as a high risk for vascular disease outcomes.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
045-0000000-0165 - GLIKOTOKSINI U ŠEĆERNOJ BOLESTI I KRONIČNIM KOMPLIKACIJAMA (Turk, Zdenka, MZOS ) ( CroRIS)

Ustanove:
Klinička bolnica "Merkur",
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac

Profili:

Avatar Url Jozo Boras (autor)

Avatar Url Spomenka Ljubić (autor)

Avatar Url Zdenka Turk (autor)

Citiraj ovu publikaciju:

Turk, Zdenka; Ljubić, Spomenka; Boras, Jozo
Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipaemia // Physiological research, 63 (2014), 2; 199-205 (međunarodna recenzija, članak, znanstveni)
Turk, Z., Ljubić, S. & Boras, J. (2014) Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipaemia. Physiological research, 63 (2), 199-205.
@article{article, author = {Turk, Zdenka and Ljubi\'{c}, Spomenka and Boras, Jozo}, year = {2014}, pages = {199-205}, keywords = {advanced glycation pathway type 2 diabetes macrovascular disease AGE/esRAGE ratio}, journal = {Physiological research}, volume = {63}, number = {2}, issn = {0862-8408}, title = {Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipaemia}, keyword = {advanced glycation pathway type 2 diabetes macrovascular disease AGE/esRAGE ratio} }
@article{article, author = {Turk, Zdenka and Ljubi\'{c}, Spomenka and Boras, Jozo}, year = {2014}, pages = {199-205}, keywords = {advanced glycation pathway type 2 diabetes macrovascular disease AGE/esRAGE ratio}, journal = {Physiological research}, volume = {63}, number = {2}, issn = {0862-8408}, title = {Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipaemia}, keyword = {advanced glycation pathway type 2 diabetes macrovascular disease AGE/esRAGE ratio} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font